Picture of NANOSONICS logo

NAN — NANOSONICS News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Citi sees ultrasound sales for Nanosonics returning to pre-COVID levels in FY22

(Updates)
    ** Shares of Nanosonics Ltd  NAN.AX  surge as much as 27.7%
to A$7.52, their biggest intraday pct gain since Aug 27, 2019
    ** Nanosonics, which manufactures and distributes ultrasound
probe disinfectors, says annual revenue up 3% at A$103.1 mln
($74.30 mln)  urn:newsml:reuters.com:*:nASX1Gb6jQ
    ** NAN anticipates a return to double-digit growth in total
revenue in FY22, as ultrasound procedures return to pre-COVID19
levels
    ** Citi expects NAN to benefit from normalisation of
ultrasound procedures in FY22, although short-term risks due to
COVID-19 exist
    ** NAN's reported FY21 NPAT of A$8.6 mln beats Citi estimate
of A$5.8 mln
    ** Citi expects FY22 core net profit of A$20.7 mln, and A$29
mln in FY23
    ** As at 0530 GMT, Nanosonics top gainer in the ASX 200
benchmark index  .AXJO 
    ** Stock at its highest since Feb. 8; posts eighth straight
session of gains
    ** About 6.2 mln shares change hands, vs the 30-day average
volume of ~599,000 shares
    
    
    ($1 = 1.3875 Australian dollars)

 (Reporting by Harish Sridharan and Dhriti Garg in Bengaluru)
 ((harish.sridharan@thomsonreuters.com))

Recent news on NANOSONICS

See all news